PCV74 - COST-EFFECTIVENESS ANALYSIS OF ROSUVASTATIN COMPARED TO ATORVASTATIN IN SPANISH PATIENTS AT MODERATE, HIGH, AND VERY HIGH CARDIOVASCULAR RISK
Abstract
Authors
M. García-Goñi L. Fácila S. Cinza X. Pinto X. Cortes M. Prades S. Aceituno